MedPath

Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC

Recruiting
Conditions
Postoperative Complications
Alcohol Use Disorder
Registration Number
NCT06864819
Lead Sponsor
University Hospitals Cleveland Medical Center
Brief Summary

This study aims to see if there's a link between a substance called phosphatidylethanol (PEth) and how patients who have surgery at University Hospitals do after surgery. PEth levels reflect the amount of alcohol use by someone over the past few weeks. This study is checking PEth levels on all patients who are planned to stay in the hospital for three or more days after surgery regardless if they drink alcohol. Specifically, it will look at if PEth levels are connected to problems that might come up during and after surgery, like confusion, lung or heart issues, needing blood transfusions, infections, unexpected intensive care unit (ICU) stays, and longer hospital stays. While there are reports of moderate alcohol consumption being good for the heart, there are other data that alcohol consumption can be harmful. Since there's not much information on how drinking alcohol affects health outcomes during and after surgery, especially for patients who are planned to be admitted to the hospital ward or ICU after surgery, this study will hopefully see if PEth levels before surgery can predict how patients do after the surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
170
Inclusion Criteria
    1. Age range: 21-79
    1. Patients undergoing elective surgery at UHCMC with planned ICU admission
    1. Patients undergoing elective surgery at UHCMC with expected in-hospital admission for three or more days
Exclusion Criteria
    1. Patients undergoing same day outpatient surgeries or expected to be admitted less than three days post-operatively
    1. Subjects who have received a blood transfusion within the past month before surgery
    1. Pregnant subjects

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Phosphatidylethanol level as measured by blood draw.Baseline
Length of ICU stay measured in daysUp to 7 days
Length of hospital stay measured in daysUp to 2 weeks
Number of perioperative complications as measured by medical record review.Up to six months

Perioperative complications including but not limited to delirium, pulmonary complications, cardiovascular complications, need for transfusion including amount transfused, post-operative infections, unexpected admission to the intensive care unit (ICU) and increased length of stay

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath